Literature DB >> 2430857

Noradrenaline release induced by ouabain and vanadate in cat cerebral and peripheral arteries.

J Marín, C F Sánchez-Ferrer, M Salaices, I Rico.   

Abstract

The effects of 10(-4) M ouabain and 10(-3) M vanadate (Na3VO4) on [3H]noradrenaline release from cat cerebral and femoral arteries was studied. Ouabain induced tritium secretion in cerebral arteries, but not in femoral ones, which was reduced by Ca suppression and potentiated by extracellular Na reduction to 11.9 mM. However, vanadate evoked tritium release from both kinds of vessels was unaffected under these experimental conditions. These data suggest: ouabain elicited secretion from adrenergic nerve endings is likely due to inhibition of the Na, K-ATPase and subsequent Ca influx through Na-Ca exchange, and vanadate action is mediated by another mechanism different to the Na pump blockade.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430857     DOI: 10.1016/0306-3623(86)90098-4

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  4 in total

1.  Effects of ouabain on isolated cerebral and femoral arteries of the cat: a functional and biochemical study.

Authors:  J Marín; C F Sánchez-Ferrer; M Salaices
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

2.  Actions of vanadate on vascular tension and sodium pump activity in cat isolated cerebral and femoral arteries.

Authors:  C F Sánchez-Ferrer; J Marín; M Lluch; A Valverde; M Salaices
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

3.  Differential effects of Na+, K(+)-ATPase inhibition by ouabain on acid secretory responses to histamine and bethanechol in the mouse isolated stomach.

Authors:  S Horie; S Yano; K Watanabe
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

4.  Effects of sodium vanadate on the smooth muscle of the rat portal vein.

Authors:  K Shimamura; S Sunano
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.